Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Scientific Reports|August 5, 2017
Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patientsFei-Yan Xiao, Jian-Quan Luo, Min Liu, et al.
Medicine|March 17, 2021
Evaluating the role of GSTP1 genetic polymorphism (rs1695, 313A>G) as a predictor in cyclophosphamide-induced toxicitiesJin-Yu Gong, Si-Yin Peng, Kai Xing, et al.
Frontiers in Immunology|September 4, 2023
Systematic Mendelian randomization study of the effect of gut microbiome and plasma metabolome on severe COVID-19Han Yan, Si Zhao, Han-Xue Huang, et al.
Iscience|July 17, 2023
Hydrochlorothiazide-induced glucose metabolism disorder is mediated by the gut microbiota via LPS-TLR4-related macrophage polarizationJian-Quan Luo, Huan Ren, Man-Yun Chen, et al.
Archives of Pharmacal Research|June 3, 2018
Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectivesMou-Ze Liu, Hai-Yan He, Jian-Quan Luo, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 31, 2015
Pharmacogenomics and herb-drug interactions: merge of future and traditionMou-Ze Liu, Yue-Li Zhang, Mei-Zi Zeng, et al.
Pharmacogenomics|September 25, 2013
Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatmentJian-Quan Luo, Lu-Yan Wang, Fa-Zhong He, et al.
Scientific Reports|November 27, 2015
SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic StudyJian-Quan Luo, Fa-Zhong He, Zhen-Min Wang, et al.
Pharmacogenetics and Genomics|April 19, 2014
Rs495828 polymorphism of the ABO gene is a predictor of enalapril-induced cough in Chinese patients with essential hypertensionJian-Quan Luo, Fa-Zhong He, Zhi-Ying Luo, et al.
Plos One|August 14, 2013
Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartanWang-Qing Chen, Yan Shu, Qing Li, et al.
Pageof 4